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Assessing, Accommodating, and Interpreting
the Influences of Heterogeneity
by ThomasA. Louis*
Hetergeneity, rngingfommeasurement emrtovaiationamong orregons, Iluenes allle ofdata
collectedforriid fsm . In Itsroleasanemes, canrIducethe p*eionof ch etheshape
ofa populationmodel, or reduce the gene y ofstudy resuts In mam contexts, however, heter istythe
primaryobjectofinfbence. Indeed, somedegreeof nie ofa alneamontam ated tha
modelisnecessaryinordertoidentifyhnportatdeterminantsoresponse. lMsreportoudlesthecausesandInfluences
of t,delops amethodsiuedtoesd teand accountfor it,dhcui s nonof l erpretation hete niFty,
andshows howitshoudinfluencestudydesign. Examplesfromdose-responem ientificationofsensitivein-
dividuals, at ofsmall areavariationsand metaanalysisprovideapped contexts.
Introduction
Withoutheterogeneity, orvariation, therewouldbe nopoten-
tial for gaining scientific information. Yet, unappreciated
heterogeneity can degrade or distort scientific interpreta-
tions.Therefore, thoughheterogeneity mayplay anegative role
in some situations, it is our lifeblood in others. This report
discussesissues, techniques, andexamples relatedtoassessing,
accommodating, interpreting, and controlling the effects of
heterogeneity. Though noabstractdefinitionofheterogeneity is
satisfactory forall settings, weshall proposeoperationaldefini-
tions that are relevant to specific scientific and practical ques-
tions. Wedonot gointo greatdetail on anyspecific issue or ex-
ample, rather we provide an overview and key into a wide
literature.
Heterogeneity canbedefinedin many wayswiththe mostin-
clusivebeing variation ingeneral. More restrictive definitions
help structure ourapproach. Heterogeneity asvariationin excess
ofabaseline modelprovides an important framework. For ex-
ample, Knuimanetal. (1), Margolinetal. (2,3), andMcCannet
al. (4) show that intra- and interlaboratory variation in the
numberofrevertantsintheAmestestfarexceedsthatpredicted
from the Poisson distribution, and we have a considerable
amountofunexplainedvariation. Interpretations oftheAmestest
shouldbebased onthe truevariability, soidentifying the excess
hasdirectvalue. Equally importantis anattempt toexplain ex-
cessvariation. Muchofthis maybeinexplicable, but some may
be accounted for by covariates such as variation in the growth
mediumandincubationtemperature. Explaining someoftheex-
cessallows improvedexperimentaldesign, and, with avalidated
modelthatrelatescovariates tooutcomes,givestheabilityadjust
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provides another instructive example. As Bailar and Louis (5)
discussforlungresponsivenesstochallenge, smokersasagroup
may be considered sensitive relative to nonmokers, yet some
smokers(eveninthesamesmokingratecategory)aremoresen-
sitivethanothers. Thisexampleidentifiesthequestionofscop-
ing the assessmentofheterogeneity. One needs togroup study




shows the importance of identifying and accounting for
heterogeneity. Considertheeffectofdiastolicbloodpressureon
riskofstroke. Bloodpressuremeasurementsaremadewither-











or overview (9). If each study uses a different measurement
system(forexample, takingtheaverageofadifferentnumberof
bloodpressurereadings), reportedslopeswillneedadjustment
before combining. Failure to do so can result in observed
heterogeneity ofslopes inexcessofthatpredictedby sampling
variability (the baseline model). In this case, theunexplainedT A. LOUIS
variation can be explained and accommodated by an error-in-
variables model.
Onemoreclassofexamples servetointroduceanotherfeature
of unappreciated heterogeneity. Vaupel and Yashin (10) and
Yashin (11) discuss "heterogeneity's ruses," wheretheshapeof
thehazardfordeathinapopulationisdifferentfromthatforany
individual. For example, each individual may have a constant
hazard (exponential distribution), butthepopulationcurvewill
showadecreasinghazard. Relatively speaking, thefraildieout
early, leavingthehardy(lowhazard)tolive. Again, atthepopula-
tionlevel, thedecreasinghazardisappropriate, butifonewishes
to study aging orpolicy impacts, an understanding ofthe ruses
and an attempt using data and theory to uncover them is vital.






show thattheexcess decreases. Thedecrease maybe true, and
surely isforthepopulation, buteachindividual'sexcessriskmay
indeed increase, but heterogeneously.
The facts discussed so far, suggest several definitions of
heterogeneity, including general variability, variability inexcess
ofabaselinemodel, variancecomponents, measurementerror,
variation in latentparameters. To these definitions we can add
heterogeneity inducedby variation indataanalyticapproaches.
In the end, heterogeneity is a vague concept and is best ap-
preciated through a series ofexamples.
Two-Stage Models
Basic
Thetwo-stage modelprovides aconvenient way to represent
variation in excess ofabaseline model. In this model we have
stageII: aparameter(vector) issampledfromadistribution; and
stageI: dataaregeneratedfromasamplingdistribution, condi-
tional ontheparameter. Thistwo-stagesamplingprocesscanbe
repeated for each experimenal unit (e.g., clinics, petri dishes,
small geographic areas), and underlies Bayes and empirical
Bayesanalysis. Forconcreteness, considerastageIIgovernedby
apriordistribution (G)thatisGaussianandthatstageIisGaus-
sian with a known variance (12,13). Letkdenoteexperimental
unit, k = 1, . . ., K, andthebasic modelbecomes:
61, 02, ... 0K are iid N(1i, r2)
YkI Ok N(Ok, u2).
This model can be extended in a wide variety of ways, in-
cludinghavingrepeatedsamplingofYvaluesforeach0, allow-
ing distributions different from the Gaussian, using unequal
sampling variances, andintroducing aregression structurefor
the Y so that the 0 values come from different, but related
distributions. Continuing with this basic model wehave:
Y1, ...,YK are (iid) N (A, U2 +r2)
and the Y, values are overdispersed relative to the sampling
distributionwithvariance a2, but itmay beexplicable.
ThismodelisthemodelIIorrandomeffectsANOVA,andtests
ofthenullhypothesisareaskingifr2 = 0. IfT2 > 0, thenwehave
variationnotaccountedforbythebaselinemodelandcanlook
for explanations through covariance adjustment. If useful





andweknow(assume)thata2 = 6, thenanaturalestimateforr2
is4. If, however, weassume 2 = 9, then -r = 1. Inpractice, we
need either direct information on sampling variation (through
replicationwithinunits)orreliableassumptions(e. g.,useofarc-
sinetransformedbinomial data) to identify T2.
Foranotherexampleofatwo-stagemodel, considerthecase
wherethe sampling distribution is Poisson (14,15). Then,
YkIOk N Poi (Ok),E (YkIOk)
= Ok,V (Yk Ok)= Ok.
Frequently, variability among the Y values is greaterthanthat
predictedbytheirsamplemean, andatwo-stage model is sug-
gested (1-3). Forexample, assuming thattheO valuesaregam-
ma with mean, g, and squared coefficient ofvariationac', we
find thatthe Y, values arenegativebinomial with:
allowing foroverdispersion. Even ifwedo notacceptthe two-
stage hierarchy, the negative binomial allows more flexible




For the fonier, allow n replications for each 0. The optimal
estimateof tisY,themeanofallobservations. Thevarianceof
Yconsistsoftwocomponents: thatinducedbythepriorandthat
inducedby the samplingdistribution. Wehave:
Y K R Yk, V(Y) =Rn_ + R-
NoticethatincreasingeitherKornwillreducethefirsttern, but
thesecondterm iscontrolledbyK, thenumberof0 valuesthat
wesampled(primaryunits). Infact, ifn = co, sothatwehave
perfect knowledge of each 0,k we still have uncertainty in
estimating;L.
Aflxedefctsanalysis, wherewewishtoestimate0,themean





ty. To get an idea of the increase, consider the ratio of the
variability for the random effect (RE) versus fixed effect (FE)
analysis. Wehave: V
RE= 1 + (n-1) p,
V
FE
wherep = i2/(a2 + 72)istheintraclass correlation. Ifn = 1 or
p=0(r = 0), thereisnovarianceinflation, otherwiseitcanbe
considerable. Thisratioiscalledthedesigneffect. Intheextreme
casewithp = 1, nobservations onanexperimentalunitareno
moreinformative (variancereducing) anoneobservationand
V,Eis ntimesVF.
The designeffect andgeneralizations thereofcanbe used to
determinehowmanyrepeatmeasurementsonaunit(n)andhow
manyunits(K)areneededtoproduceadesiredaccuracy. Setting
n = 1 minimizes the number of observations, but generally
repeatobservationsonaunitaremorerelevantorlessexpensive
thanaddingunits, soann > Iusuallyproducestheopimalsolu-
tionunder resource constraints.
The decision to use fixed or random effects depends on in-
ferentialgoals, anddifferencesingoalsunderliethecurrentcon-
troversyoverwhentousemetaanalysis(16). Therandomeffects
approach produces considerably larger standard errors on an
estimated treatment effectthandoesthefixedeffectsanalyses.
Peto and colleagues argue in favorofinferences limited to the
meta-analyzed studiesandusedfixedeffects(17). Othersdesire
abroadenedinferencetothepopulationofsimilarstudies, and
this promotes random effects (18). The narrow inference has a
well-definedreferencepopulationbutdoesnoteasilygenealize.









(the SEdependsboth onthenumberofstudies andthesample
size for each study), and shows that the stage II variability is







N(10, 32). Thisinformationisofpolicyinterest. Forexample, it
isvirtuallyimpossiblefortheretobeanegativecoachingeffect
Tnbke 1. Theeffectofcoachn onSATscores(19).
Coachingeffect
Matched/
Parameter Uncontrolled Controlled randomized
A 41 15 10
SE(ji) 10 5 4
t 25 14 3
Table2. Metaanlysis ofvinylchloide fron
Beausmont andBresow (20).a
Relative p-Values
Site risk Ho:RR= 1 Heterogeneity
Liver 5.2 0.0001 0.002
Brain 1.7 0.01 0.100
Lung 1.1 Notsignificant 0.060
There werenine studies.
in the randomized approach applied to populations similar to
thoseused inthecurrentstudies.
TestsforheterogeneityinaGaussianframeworkaskifT2 =0.
In general, these tests are less informative than reporting an
estimate, where one can determine ifthe excess variation is a
threattointerpretationorgeneralization. Consider,forexample,
themetaanalysisconductedbyBeaumontandBreslow (20) on
the cancer risk from vinyl chloride. Table 2 shows their sum-
mary, indicating statistically significant relative risks for liver
and brain, but not for lung tumors. For liver, the test for
heterogeneity conclusively shows that the studies are not
estimating acommonrelativerisk(thereisheterogeneity). An
estimatedvariancecomponentwouldallow oneto seeifvaria-
tion in relative risks is sufficient to produce values below 1 (a
qualitativeinteraction)orsimplyvariationalltotherightof1 (a
quantitativeinteraction). Theformercausesproblems in inter-
pretation, thelatterdoes not. Both setthe stage forfinding ex-
planations fortheexcess variation.
Example
An early two-stage analysis of water contamination was
publishedbyVon Mises (21). Ineachof3420sampling sites, 5
samples were taken and the number ofcontaminated samples
recorded. Table 3 gives the data and expected frequencies
(rounded) underthebinomial distribution, computed with the
estimatedcontminationprobabilityof0.025. Forthiseventpro-
bability, thebinomialassumptionpredictsfartoofewoccurences
of2 to5, andatwo-stagevariancecomponents model cancap-
turetheexcessvariationamonggeopraphic areas. The sample
variance of the observed contaminations is 0.1885, which is




1)'. Specifically, with0 thebinomialparameter:
E(O) =-A, V(O) = A4l -.u)/(M + 1).
FromtheVonMisesdata, weobtaini =0.025, M = 6.2. The
62showshighapriorivariation, whereas anM -+ oo wouldin-
dicate nopriorvariation.
Wecangofurtherwiththisexampleandfreeourselves from
assuming a specific parametric shape for the priorby using a
nonparametric estimate. Laird (22) introduced thealgorithm,
andweobtainadiscretepriorwithmasses(0.606,0.261,0.092,
















Sometimes heterogeneity can be reduced or eliminated by a
data transform. Consider data from amulticenter clinical trial
analyzed by the model:
Yjk = ak + bk Tj + ejk,
whereT, = 0forj = 1 (treatment 1),T, = 1 forj = 2 (treatment
2), kdenotestheclinic, the avaluesandbvalues arerandomef-
fects, andtheYvalues aretreatment means. Ifthedataareactual-
ly log-normal, the propermodel is:
* * *
log (Yjk) = ak + bk Tj + ejk
withb* =b, wehavethesituation whereV(bj) < 0butV (b) =
0. Thistreatment-by-clinic random interactioneffect inthe un-
transformed scaleis inducedbyclinicshavingdifferentbaseline
responses (thea,vary) and the modelbeing misspecified. Ran-
domeffects models in the untransformed scale canpick up the
interaction induced by misspecification and serve to make the
standard analysis more robust. Notice that interaction induced
by these transformation models is never qualitative (all the bk
are of the same sign) so combining evidence is scientifically
valid. Therandom-effectsmodeldelivers anestimatedvariance
forthe treatmenteffectthat accounts fortheheterogeneity.
Estimating Individual Components
Now, let us consider estimating the underlying mean for in-
dividual units (the o for the Gaussian example). Ifwe knew jA
and r2, thedistribution of o givenyk(theposteriordistribution)
is Gaussian with:
E(OkIYk) = + (1 -B) (Yk- 1)
V(Ok Yk)
= (1-B) a2,
whereB = oa/ (a2 + 72). Noticethattheobserved value(Y) is
shrunkentowardstheprior mean(u) by anamountthatdepends
ontherelativesizesofthepriorandsamplingvarianceandthat
thevariance is less than thesampling variance a2.Ifa2 is small
(e.g., ifY, is an average ofseveral replicates), then B is small
and very littleshrinkagetakesplace. Similarly, ifr2isrelative-
ly large (there is very little information apriori) we have little
shrinkage. Indeed, ifB = 0, the conditional expectation ofok is
Ykl the usual result. If a2 is relatively large, considerable
shrinkage occurs, stabilizing the estimate atthe expense ofad-
ding somebias. Theserelations expressthegeneralguidelineof
modeling where for small sample sizes control ofvariability
dominatesanalyticgoals. Forlargesamplesizesbiasreduction
dominates. Strikingtheappropriatetradeoffcomes fromscien-





i2 { (Yk Y)2 _2}+ ,
where + setsnegativenumbersto0. UsingtheseempiricalBayes
estimates, whereinformation fromallunits is usedtoestimate
asingleunit'smean, canimproveestimationperformance. Ap-
plicationsbyEfronandMorristotoxoplasmosisincidence(24),
Laird and Louis to carcinogenicity testing (23), Rubin to law
school admissions criteria (26), Louis (27) and Thkey (28) to
histogramestimates, Clayton andKaldor (29) to relative risks,
Stroud(30)tosmallareaanalysis, HuiandBergertolongitudinal









ofshorter length than the classical intervals (13,34). This em-
pirical Bayes advantage holds even when the intervals are












severalunits, the meanY istotally efficient, but wedoneed to
account for heterogeneity to get a proper standard error.
However, considerestimatinganonlinearfunctionofthemean
1L; forexamplee". The estimate ey will nothaveexpectatione"
even for large sample sizes; it is inconsistent. A consistent
estimate requires accounting fortheheterogeneity.
Correlation
Discovery andaccountsofheterogeneity arekey ingredients
for theanalysis oflongitudinal data (35,36). Atthe mostbasic
level, consider the correlation between lung function
measurements (theforcedexpiratoryvolume) inadultsat3-year




hasbeen explained. It is important tonotethatthis covariation
ismeasuredusingresidualsfromthemodelproducingexpecta-
tions, not fromthe raw data.
Unexplained (co)variationproducesavariety ofphenomena
inlongitudinaldata. Considerrelatingadjacentresidualsbyplot-
ting e,,+ versus e,, where the e values are residuals from a
model. A plot with slope 1 represents tracking where an in-
dividual'sdeviationfromthepopulationpredictiontendstostay
put. Aslopelessthan 1 indicatesregressiontothemean, where
the subsequentdeviationtendstobelessextreme thanthecur-
rentvalue. Aslopegreaterthan 1 indicatesthehorserace, where
residuals tend to increase in absolute value. The name derives
fromtheideathathorsesintheleadtendtoberunningfastestand
increase their lead. Ofcourse, a plot showing random scatter
with slope 0indicates noassociation.
Asoneincludesadditional, effectivecovariates inthemodel,
these residual plots change, sometimes with changed slope,
usually withlessextremerelations. Again, asthemodelexplains
additional(co)variation, wechangethestructure. Forexample,
one explanation for the horse race comes from assuming that
covariatesnotyetinthemodel(e.g., smoldng), influencetherate
ofchange inlung function. Withoutthecovariateinthemodel,
smokers have the fastestdecline and the lowest lung function.
Theirleadincreasesovertime. Oncethesmokingcovariateisin-
cluded, residuals compare smokers to smokers, and residuals
haveachancetobebothpositiveandnegative. Thoughtherestill
may be a horse race phenomenon, it will be less and could be




Unappreciated heterogeneity can influence scientific and
policyconclusionsbydisguisingtrueparametervaluesandrela-
tional shapes. Berksonprovidedtheclassicexample, wherewe
are relating variables through a linear model. For specificity,
consider the model: toxicity = a + b * dose, where we take
measurementsondoseandtoxicity. Consideralargesample, so








(a) If different experiments are performed with different
measurement accuracies, then failure to account for thesedif-
ferences will produce apparently different slopes. Any meta
analysisofexperimentalresultswillrequireadjustmenttoacom-
monbasis. (b)Pbssiblymoreimportantly, eventhoughtheunad-
justed slope is appropriate for relating measured dose to
response, itisinappropriatewhenmakingpolicy recommenda-
tions. Forexample, manystudiesreportonthepositiverelation





Many authors have discussed the consequences oferrors in




in performing the necessary adjustments. In studies relating a
riskfactortoaresponseinthepresenceofaconfounder, Kupper
(6) shows thatunreliability in measurementofthe confounder





The effects ofunaccommodated heterogeneity can be more
dramatic than slope attenuation. Considerthe linearmodel
Y = a + bx + error
wherexisthetrueregressor. Lettheobservedregressor(X)con-
ditional on the true regressor be distributed as a log-normal
variablewithmean x. Then, the regressionusingtheobserved
regressoris:
y = a + bXP+ error,
wherep < 1, soalinearrelationisconvertedtononlinear. Bailar
et al. (41) suggest that this type ofphenomenon (operating as
variationintrueslopefromrodenttorodent)mayproducetheap
parent lack of conservatism for linear extrapolation of dose-
responserelations. Thedose-responsecurveforvinylchloride
is aclassic example.
When we start with a nonlinear model, such as a logistic
regression or a multistage model for carcinogenicity,
heterogeneityduetonoisyregressorsorduetovariationsintrue
slopesfromunittounit(thecompoundmodel)changetheshape
ofthe relation. Techniques areavailable forestimating and ad-





or forceofmortality, is defined as:
At(t)dt = pr(death in (t,t+dt)I alive at t).
With S(t) the survival curve:
p4t) = -Flog (S(t))
S(t)= exp [-U(t)], U(t) =ft IL(t)dt
0
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Assume that each individual in a population has a hazard
depending on a parameter 0 that multiplies a baseline hazard
(proportional hazards), andthat0 variesfrompersontoperson
according to aprobability distribution G (again, the two-stage
model). Then, for the population:
SG(t) = ef H(t) dG(O)
and
IzG(t) h(t) *EG(6IT>t),
where h is the basline hazard, and H is its integral. It can be
shown the EG (0 I T>t) is decreasing in t so that the shape
ofit (t) is different fromthatofh(t).
VaupelandYashin(10)giveseveralexamplesofthisdifference
in shape. The easiest example has h(t) 1 and Gputting mass
ontwopoints01<02. Then, thougheachindividual hasacons-




rors in variables regression, u,G(t) is theappropriatepopulation




terval oftime, some age-specific hazards are higher than they
wouldhavebeenwithouttheintervention. Someofthefrail in-
dividuals who would havedied earlier ifthey hadcontinued to
smoke have been sent to deaths at later ages. This is another
manifestationofSimpson'sparadox; aptlyputasanintervention
thatisgoodformen; goodforwomen; butappearsbadforpeo-
ple. Vaupel andYashin(1J) call thistheapparentfailureofsuc-




carcinogen bioassay illuminates several issues related to
heterogeneity. Consider a bioassay comparing lifetime tumor
ratesbetweenanexposedandcontrolgroupofrodents, eachwith
50rodents. Table4presentstypicaldatawhenall tumors occur
intheexposedgroup. TheFisher'sexactone-sidedp-valueisap-
proximately(0.5)x, sothatifxislessthan5, thep-valuewill ex-
ceedtheusual level forstatistics significance. Thep-values for
X = 0,1,2,3,4,5 are 1.000,0.500,0.247,0.121, 0.059, and0.028.
However, inmanysituationspathologistswillreportthatevenan
X = 3 isbiologically significantbecauseinalongseries ofex-
perimentsvirtually notumorsofthetypebeingconsideredhave
been found in the control group.
Thisdissensusbetweenthestatisticalprocedureandscientific
opinion can be explained and rectified by a two-stage model
wherethecontrol rateforthecurrentexperiment isconsidered
tobesampled from apriordistribution. Inthecasewe are con-
sidering, thispriorputs almost all weight on acontrol rateof0
and is equivalent to increasing the control sample size. For
Ibke4. Hypothetcal reslt from acarcinogenbioasay.
Control Exposed Total
Tumor 0 x x
Notumor 50 50-x 100-x
Total 50 50 100
'Theone-sided Fisher'sexactp-value isapproximately (0.5)'.
example, considerthesituationifTable4weremodifiedtohave
450controlrodents, nonewiththetumorinquestion. Then, the
one-sided Fisher's exact test is approximately (0.1)x and three





that surrounded the assay for DMT (dimethylterephthalate),
wherethedatashowed2%, 16%, and27% lifetimeincidenceof
alveolar/broncheolaradenomasandcarcinomasinmalemicefor
the control, low-, and high-dose groups (p<0.0001), but
previous control groups in the same laboratories had rates of
10%, 13%, and 18% (50). Refinementsareneededtoincorporate
time-until-tumor and cause-of-death information, and the ap-
proachshouldbeincludedasaformalmethodoffocusingdiscus-
sionofbioassayresults. AsevidencedbyFreedman(5S),thecar-



















unitofanalysis (e.g., theindividual, thepublication, thesmall
geographic area), the baseline model (e.g., logistic dose
response, PRissoncounts), theformofheterogeneity(e.g., gam-
ma, Gaussian), and the type of units to be admitted to the
analysis. Werefertothetypesofunitsanalyzedasscoping, and
itconcernsdefiningthetypesofunitsthatcanbeexpectedtobe
related by the heterogeneity distribution. Too broad a scoping
willproduceestimatedpriorvariation solarge as tounduly in-
flatethestandarderrorofparameterestimatesandreducethead-
vantage in estimating unit-specific parameters of combining
evidence over units. Too narrow a scoping produces unstable





general approach allows covariates toadjustthepriordistribu-
tion. Forexample, inperformingasmallareaanalysisofdisease
incidence(29), thepriorcanbeadjustedforage, gender, andrisk
factorsbybuildingaregressionmodelforthepriormean. This
approachallowsforbroadenedinferencesandisthemodel-based
method forexplaining unexplained variation.
Useofhistorical controlsinthebioassayprovidesagoodex-
ampleoftheissues. Theanalystneedstodecidewhatcontrolsto





trols and theoperating characteristic ofthetestprocedure.
Amato andLagakos (55) analyzetheeffects ofdisagreement
amongpathologists whencharacterizing the tumors in rodents
















importanttothedesign, conduct, analysis, andinterpretationof
statistical studies. Key issues include determining baseline
modelsanddefininganalytic goals. Ifthegoalsareprimarilyto
make inferences at the population level, then heterogeneity
modelingisquiterobustandgenerally servestoexpandtheflex-
ibility of population models to represent expectations and
variances. If,however, inferencesaredirectedattheunit-specific
level, considerablecareisneededinspecifyingbaselinemodels
andformsforheterogeneity. Commonly, truereplications atthe
unitlevel areunavailable, and models willbebased on acom-
binationofscientificreasonablenessandstatistical/mathematical
convenience. Usually, thespecificformschosenarenotuniquely
best for the observed data, and careful interpretation coupled
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